Wu Sikai, Chen Xiaowei, Bai Guangyu, Liu Yang, Yang Zhenlin, Gao Shugeng
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Transl Lung Cancer Res. 2025 Apr 30;14(4):1274-1289. doi: 10.21037/tlcr-2025-41. Epub 2025 Apr 16.
The safety, feasibility, and potential benefits of uniportal video-assisted thoracoscopic surgery (U-VATS) pneumonectomy remain to be investigated. This study aimed to evaluate the postoperative outcomes, survival prognosis, and recurrence patterns in patients undergoing U-VATS versus those undergoing open pneumonectomy. The feasibility of U-VATS pneumonectomy in patients receiving neoadjuvant systemic therapy was also assessed.
Patients with non-small cell lung cancer (NSCLC) underwent thoracic surgeries at the Cancer Hospital, Chinese Academy of Medical Sciences (CHCAMS) from January 2017 to December 2022. Among these patients, those who underwent U-VATS or open pneumonectomy were included in our study. Propensity score matching (PSM) with a 3:1 ratio was conducted to balance the baseline characteristics between the groups. We compared perioperative outcomes and recurrence patterns between the two groups.
A total of 457 patients who underwent pneumonectomy were included in our study, with 348 in the open pneumonectomy group and 109 in the U-VATS group. After PSM, 334 patients (231 in the open group and 103 in the U-VATS group) were available for subsequent analyses. Patients who underwent U-VATS pneumonectomy experienced shorter postoperative hospital stays (P<0.001). No significant differences were observed in the 5-year overall survival (OS) rate (P=0.19) or the 5-year recurrence-free survival (RFS) rate (P=0.37) between the two groups. Additionally, subgroup analysis of patients receiving neoadjuvant systemic therapy indicated those in the U-VATS group did not exhibit significant differences in recurrence patterns between the two groups.
Patients with NSCLC undergoing U-VATS pneumonectomy exhibit postoperative outcomes, survival rates, and recurrence patterns that are not inferior to those of patients undergoing open pneumonectomy.
单孔电视辅助胸腔镜手术(U-VATS)肺切除术的安全性、可行性及潜在益处仍有待研究。本研究旨在评估接受U-VATS肺切除术与开放性肺切除术患者的术后结局、生存预后及复发模式。同时评估了U-VATS肺切除术在接受新辅助全身治疗患者中的可行性。
2017年1月至2022年12月期间,在中国医学科学院肿瘤医院(CHCAMS)接受胸外科手术的非小细胞肺癌(NSCLC)患者纳入研究。其中,接受U-VATS或开放性肺切除术的患者纳入本研究。采用3:1的倾向评分匹配(PSM)来平衡两组间的基线特征。比较两组的围手术期结局和复发模式。
本研究共纳入45名接受肺切除术的患者,其中开放性肺切除术组348例,U-VATS组109例。PSM后,334例患者(开放性手术组231例,U-VATS组103例)可用于后续分析。接受U-VATS肺切除术的患者术后住院时间较短(P<0.001)。两组间5年总生存率(OS)(P=0.19)或5年无复发生存率(RFS)(P=0.37)无显著差异。此外,对接受新辅助全身治疗患者的亚组分析表明,U-VATS组患者在两组间的复发模式上无显著差异。
接受U-VATS肺切除术的NSCLC患者的术后结局、生存率和复发模式并不逊于接受开放性肺切除术的患者。